Bel   ·  Eng   ·  Rus  |    Text only  |   NASB in Facebook NASB in Vkontakte NASB in Twitter NASB in Instagram NASB in Youtube NASB in LinkedIn NASB in SlideShare rss Mail 
   
The Official Internet Portal of the President of the Republic of Belarus
The Official Internet Site of the Council of Ministers of the Republic of Belarus
List of Administrative Procedures Carried out by NAS of Belarus and its Organizations
The national legal Internet portal of the Republic of Belarus
The Academy of Public Administration under the aegis of the President of the Republic of Belarus
Internet portal Youth of Belarus
Republican Center for Technology Transfer

Lectures on latest developments in field of HIV to be delivered by Chinese scientists at NAS of Belarus

Homepage / News / News Archive / 2018 
 

01.06.2018 On 8 June 2018, at 3:00 p.m., open lectures on the latest developments in the field of HIV will be delivered by Chinese scientists at the NASB Presidium. Professor Shibo Jiang, Fudan Univerdity (Shanghai, China), will speak on virus penetration into the cell and viral inhibitors; and Doctor Jinghe Huang, Fudan University (Shanghai, China), will report on broadly neutralizing antibodies against HIV-1.

Professor Shibo Jiang is a world-renowned expert in the development of antiviral drugs and vaccines. He discovered the first effective anti-HIV peptide, and his patent was licensed to create the first FDA approved peptide inhibitor of HIV, namely Fuzeon (enfuvirtide or T20), widely used in clinical practice for the treatment of HIV infection. He developed JB01 protein which is the first anti-HPV therapeutic drug.

Doctor Jinghe Huang has considerable experience in the field of research of broadly neutralizing antibodies. From AIDS patients, she isolated a series of broadly neutralizing antibodies known as 10E8, 35O22 and N6. She has published the results in the most prestigious scientific journals, such as Nature, Immunity, Nature Protocols, JEM и JCI.



Возврат к списку

Homepage / News / News Archive / Back to Top of Page